Affiliation:
1. From the Department of Medicine, Divisions of Metabolism, Endocrinology, and Nutrition (M.C.C., J.E.H., J.Q.P., J.D.B.) and Medical Genetics (S.S.D.); and the Department of Family and Child Nursing (E.S.M.), University of Washington, Seattle.
Abstract
Abstract
—High hepatic lipase (HL) activity is associated with an atherogenic lipoprotein profile of small, dense LDL particles and lower HDL
2
-C. Intra-abdominal fat (IAF) is positively associated with HL activity. A hepatic lipase gene (
LIPC
) promoter variant (G→A
−250
) is associated with lower HL activity, higher HDL
2
-C, and less dense LDL particles. To determine whether the
LIPC
promoter polymorphism acts independently of IAF to regulate HL, 57 healthy, premenopausal women were studied. The
LIPC
promoter A allele was associated with significantly lower HL activity (GA/AA=104±34 versus GG=145±57 nmoles · mL
−1
· min
−1
,
P
=0.009). IAF was positively correlated with HL activity (
r
=0.431,
P
<0.001). Multivariate analysis revealed a strong relationship between both the
LIPC
promoter genotype (
P
=0.001) and IAF (
P
<0.001) with HL activity. The relationship between IAF and HL activity for carriers and noncarriers of the A allele was curvilinear with the carriers having a lower apparent maximum level of plasma HL activity compared with noncarriers (138 versus 218 nmoles · mL
−1
· min
−1
,
P
<0.001). In addition, the
LIPC
A allele was associated with a significantly higher HDL
2
-C (GA/AA=16±7 versus GG=11±5 mg/dL,
P
=0.003). We conclude that the LIPC promoter A allele attenuates the increase in HL activity due to IAF in premenopausal women.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cardiology and Cardiovascular Medicine
Cited by
68 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献